Literature DB >> 30282801

Sirtuin 7-mediated deacetylation of WD repeat domain 77 (WDR77) suppresses cancer cell growth by reducing WDR77/PRMT5 transmethylase complex activity.

Hao Qi1, Xiaoyan Shi2, Miao Yu1, Boya Liu1, Minghui Liu1, Shi Song1, Shuaiyi Chen1, Junhua Zou1, Wei-Guo Zhu3, Jianyuan Luo4.   

Abstract

The histone transmethylase complex comprising WD repeat domain 77 (WDR77) and protein arginine methyltransferase 5 (PRMT5) catalyzes dimethylation of H4R3 (H4R3me2) and drives cancer cell proliferation and migration, but its regulation is not fully understood. Here, we report that sirtuin 7 (SIRT7) directly deacetylates WDR77 and that this deacetylation interferes with the WDR77-PRMT5 interaction and suppresses proliferation of human colon cancer HCT116 cells. Using co-expression in HEK293T cells and co-immunoprecipitation assays, we observed that SIRT7 deacetylates WDR77 at Lys-3 and Lys-243, which reduced of WDR77's interaction with PRMT5. More importantly, this reduction suppressed the transmethylase activity of the WDR77/PRMT5 complex, resulting in a reduction of the H4R3me2 modification. Rescue of the WDR77-KO HCT116 cells with a WDR77-2KR (K3R and K243R) variant yielded cell migration and proliferation rates that were significantly lower than those of WDR77-KO HCT116 cells rescued with WT WDR77. In summary, SIRT7 is a major deacetylase for WDR77, and SIRT7-mediated deacetylation of WDR77 at Lys-3 and Lys-243 weakens the WDR77-PRMT5 interaction and activity and thereby suppresses growth of cancer cells.
© 2018 Qi et al.

Entities:  

Keywords:  H4R3me2; SIRT7; WDR77; cell proliferation; colon cancer; epigenetics; histone methylation; post-translational modification (PTM); protein acetylation; transmethylase

Mesh:

Substances:

Year:  2018        PMID: 30282801      PMCID: PMC6240876          DOI: 10.1074/jbc.RA118.003629

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Quantitative proteome-based systematic identification of SIRT7 substrates.

Authors:  Chaohua Zhang; Zichao Zhai; Ming Tang; Zhongyi Cheng; Tingting Li; Haiying Wang; Wei-Guo Zhu
Journal:  Proteomics       Date:  2017-07       Impact factor: 3.984

2.  Old enzymes, new tricks: sirtuins are NAD(+)-dependent de-acylases.

Authors:  Matthew D Hirschey
Journal:  Cell Metab       Date:  2011-11-17       Impact factor: 27.287

Review 3.  Sirtuin 7 in cell proliferation, stress and disease: Rise of the Seventh Sirtuin!

Authors:  Shashi Kiran; Tarique Anwar; Manjari Kiran; Gayatri Ramakrishna
Journal:  Cell Signal       Date:  2014-11-27       Impact factor: 4.315

4.  Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription.

Authors:  Ethan Ford; Renate Voit; Gregory Liszt; Cornelia Magin; Ingrid Grummt; Leonard Guarente
Journal:  Genes Dev       Date:  2006-04-17       Impact factor: 11.361

5.  Altered expression of SIRT gene family in head and neck squamous cell carcinoma.

Authors:  Chi-Chih Lai; Pai-Mei Lin; Sheng-Fung Lin; Cheng-Hsien Hsu; Hsin-Ching Lin; Ming-Luen Hu; Cheng-Ming Hsu; Ming-Yu Yang
Journal:  Tumour Biol       Date:  2013-03-12

Review 6.  Sirtuins in mammals: insights into their biological function.

Authors:  Shaday Michan; David Sinclair
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

7.  Novel protein-protein interactions of TPPII, p53, and SIRT7.

Authors:  Jarmila Nahálková
Journal:  Mol Cell Biochem       Date:  2015-07-14       Impact factor: 3.396

8.  SIRT7-dependent deacetylation of the U3-55k protein controls pre-rRNA processing.

Authors:  Sifan Chen; Maximilian Felix Blank; Aishwarya Iyer; Bingding Huang; Lin Wang; Ingrid Grummt; Renate Voit
Journal:  Nat Commun       Date:  2016-02-12       Impact factor: 14.919

9.  SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis.

Authors:  Xiaolong Tang; Lei Shi; Ni Xie; Zuojun Liu; Minxian Qian; Fanbiao Meng; Qingyang Xu; Mingyan Zhou; Xinyue Cao; Wei-Guo Zhu; Baohua Liu
Journal:  Nat Commun       Date:  2017-08-22       Impact factor: 14.919

10.  Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity.

Authors:  Meng-Chiao Ho; Carola Wilczek; Jeffrey B Bonanno; Li Xing; Janina Seznec; Tsutomu Matsui; Lester G Carter; Takashi Onikubo; P Rajesh Kumar; Man K Chan; Michael Brenowitz; R Holland Cheng; Ulf Reimer; Steven C Almo; David Shechter
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more
  12 in total

1.  USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells.

Authors:  Yang Su; Chenming Wu; Yiming Chang; Lei Li; Yuping Chen; Xuebing Jia; Xinshu Wang; Ying Lv; Bentong Yu; Jian Yuan
Journal:  Breast Cancer Res Treat       Date:  2022-08-30       Impact factor: 4.624

2.  Glutathionylation Decreases Methyltransferase Activity of PRMT5 and Inhibits Cell Proliferation.

Authors:  Meiqi Yi; Yingying Ma; Yuling Chen; Chongdong Liu; Qingtao Wang; Haiteng Deng
Journal:  Mol Cell Proteomics       Date:  2020-08-31       Impact factor: 5.911

3.  PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours.

Authors:  Hong-Feng Yuan; Man Zhao; Li-Na Zhao; Hao-Lin Yun; Guang Yang; Yu Geng; Yu-Fei Wang; Wei Zheng; Ying Yuan; Tian-Qiang Song; Jun-Qi Niu; Xiao-Dong Zhang
Journal:  Acta Pharmacol Sin       Date:  2022-01-19       Impact factor: 7.169

4.  SIRT7 Deacetylates STRAP to Regulate p53 Activity and Stability.

Authors:  Miao Yu; Xiaoyan Shi; Mengmeng Ren; Lu Liu; Hao Qi; Chi Zhang; Junhua Zou; Xiaoyan Qiu; Wei-Guo Zhu; Ying E Zhang; Wengong Wang; Jianyuan Luo
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

5.  SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.

Authors:  Ya-Fei Lu; Xiao-Peng Xu; Xiao-Peng Lu; Qian Zhu; Ge Liu; Yan-Tao Bao; He Wen; Ying-Lu Li; Wei Gu; Wei-Guo Zhu
Journal:  Oncogene       Date:  2020-05-13       Impact factor: 9.867

6.  PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.

Authors:  Liu Yang; Da-Wei Ma; Yue-Peng Cao; Dong-Zheng Li; Xin Zhou; Ji-Feng Feng; Jun Bao
Journal:  Theranostics       Date:  2021-01-27       Impact factor: 11.556

7.  Germ-line mutations in WDR77 predispose to familial papillary thyroid cancer.

Authors:  Yanyang Zhao; Tian Yu; Jie Sun; Feiliang Wang; Chaoze Cheng; Shurong He; Lan Chen; Donghui Xie; Liping Fu; Xuhuizi Guan; An Yan; Yao Li; Gang Miao; Xiaoquan Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 11.205

Review 8.  SIRT7: a sentinel of genome stability.

Authors:  Ming Tang; Huangqi Tang; Bo Tu; Wei-Guo Zhu
Journal:  Open Biol       Date:  2021-06-16       Impact factor: 6.411

Review 9.  PRMT5 function and targeting in cancer.

Authors:  Hyungsoo Kim; Ze'ev A Ronai
Journal:  Cell Stress       Date:  2020-07-13

Review 10.  The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy.

Authors:  Guo Li; Yuan Tian; Wei-Guo Zhu
Journal:  Front Cell Dev Biol       Date:  2020-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.